Terumo Corporation (TRUMY)
Makes medical devices for heart surgery, dialysis, injections, and blood processing worldwide
$14.04+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-17.4%
The outlook
Terumo trades at $14.04, positioned near the lower end of its 52-week range. Analyst coverage appears thin, and the stock sits mixed relative to its moving averages. The trailing P/E of 25.1 reflects a premium valuation for the current price level.
What’s behind the score
Price trendMixed vs its moving averages
52-week range26% of the way from its 52-week low to high
Market cap
$20.71B
52-wk high
$19.60
52-wk low
$12.08
50-day avg
$13.95
200-day avg
$14.14
Trailing P/E
25.1